Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

DR
FDA Approves Unknown Drug — DR REDDYS

# FDA Approves Dr. Reddy's Generic Drug Application Dr. Reddy's Laboratories has received FDA approval for ANDA214733, expanding its generic pharmace...

ZYDUS
FDA Approves Unknown Drug — ZYDUS LIFESCIENCES

Zydus Lifesciences announced that FDA has granted approval for its generic drug submission referenced by ANDA217758, potentially impacting the market ...

DR
FDA Approves Unknown Drug — DR REDDYS

DR REDDYS announced the FDA's approval of its ANDA215820 on May 15, 2026, which is expected to broaden its commercial footprint once the product launc...

Federal
Stephen I. Miran Resigns from Federal Reserve Board

Stephen I. Miran has submitted his resignation as a member of the Federal Reserve Board. His resignation will become effective when or shortly before ...

Federal
Fed Releases Survey Results on Discount Window Operations and Reserve Balance Management

The Federal Reserve Board published findings from two surveys of senior bank financial officers regarding their preferences on discount window operati...

Amneal
FDA Approves TRETINOIN — Amneal Pharmaceuticals NY LLC

# FDA Approves Amneal Pharmaceuticals' Generic Tretinoin Topical Formulation Amneal Pharmaceuticals NY LLC received FDA approval for its generic tret...

Renova
FDA Approves L-GLUTAMINE — Renova Pharmaceuticals LLC

# FDA Approves Renova Pharmaceuticals' Generic L-Glutamine Oral Formulation Renova Pharmaceuticals LLC has received FDA approval for its generic L-gl...

CHIESI
FDA Approves Unknown Drug — CHIESI

# FDA Approves Chiesi's New Drug Application NDA219622 Chiesi Pharmaceuticals has received FDA approval for a new drug candidate under application ND...

Ionetix
FDA Approves GALLIUM GA-68 PSMA-11 — Ionetix Corporation

Ionetix Corporation announced the FDA approval of Gallium Ga-68 Gozetotide, a generic version of the prostate cancer imaging agent PSMA-11, which is e...

Federal
Federal Reserve releases 2025 Economic Well-Being of U.S. Households report

The Federal Reserve Board published its annual assessment of American household economic conditions for 2025. The report provides data on household fi...

BEONE
FDA Approves Unknown Drug — BEONE MEDICINES USA

On May 13, 2026, BEONE MEDICINES USA may experience a significant market impact with the likely approval of a new drug, though the specific substance ...

Caplin
FDA Approves FOSCARNET SODIUM — Caplin Steriles Limited

Caplin Steriles Limited has received FDA approval for its ANDA220068 application, granting it authorization to market foscarnet sodium injection in th...

Federal
Fed Terminates Enforcement Actions Against F&M Holding and Thread Bancorp

The Federal Reserve Board has terminated enforcement actions with F&M Holding Company, Inc. and Thread Bancorp, Inc. The action indicates these instit...

FDA
FDA Finalizes Food Chemical Safety Program, Launches BHT and ADA Reassessment

The FDA has finalized its post-market assessment program for food chemicals and initiated a reassessment of BHT and ADA safety. This action is part of...

FDA
FDA Solicits Input on Drug Repurposing Initiatives for Unmet Medical Needs

The FDA announced it is seeking stakeholder input on drug repurposing efforts to address unmet medical needs across various diseases and conditions. T...

Encube
FDA Approves ESTRADIOL — Encube Ethicals, Inc.

# FDA Approves Estradiol Transdermal Patch from Encube Ethicals Encube Ethicals, Inc. received FDA approval for its generic estradiol transdermal pat...

Federal
Federal Reserve approves applications by Columbia Bank MHC and Columbia Financial

The Federal Reserve Board has approved related applications submitted by Columbia Bank MHC and Columbia Financial, Inc. The approval allows these enti...

FDA
FDA Approves Bizengri for Rare Bile Duct Cancer Under Priority Program

The FDA granted approval for Bizengri (zenocutuzumab-zbco), marking the seventh approval under the National Priority Voucher Pilot Program. The drug t...

FDA
FDA Issues Guidance on Postapproval Pregnancy Safety Studies for Drugs

The FDA released final guidance recommending methodologies for studying drug and biologic safety during pregnancy in the postapproval setting. The gui...

MICRO
FDA Approves Unknown Drug — MICRO LABS

# FDA Approves Micro Labs Generic Drug Application Micro Labs has received FDA approval for its abbreviated new drug application (ANDA 218558), expan...